en-USzh-TW

ANDRÁS GUTTMAN, Ph.D., D.Sc., Scientific Advisory Board 

András Guttman is a research professor at the Barnett Institute in Northeastern University (Boston, MA), also heading the Horváth Laboratory of Bioseparation Sciences (HLBS) in University of Debrecen (Hungary) and was recently named as Marie Curie Chair Professor by the European Commission. His fields of research interest are glycomics, bio-marker discovery and microfabricated device technology.

Professor Guttman previously held industrial research positions at Novartis (La Jolla, CA), Genetic Bio-systems (San Diego, CA) and Beckman Instruments (Fulleton, CA). He has contributed more than 200 scientific publications, 30 book chapters, edited several textbooks and holds 18 patents. He is the president of the Hungarian Chapter of the American Chemical Society, board member of CASSS and on the editorial panels of numerous international scientific journals. Dr. Guttman graduated from the University of Veszprem (Hungary) in chemical engineering, where he also received his Ph.D. He was awarded the Analytical Chemistry Award of the Hungarian Chemical Society in 2000 and became a member of the Hungarian Academy of Sciences in 2004.

Ming-Jhy Hseu, Ph.D. Scientific Advisory Board

Ming-Jhy Hseu joined BiOptic Inc. in 2010 as a Technical Advisor in Taipei, Taiwan, where his current goal focuses on the application of capillary electrophoresis technique in resolving the formation of immunocomplex in the reaction of antigen and antibody. He earned his Ph.D. from Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan. Previously, he was a research assistant fellow at Institute of Biological Chemistry, Academia Sinica, Taiwan and also an adjunct lecturer at Institute of Biochemical Sciences, Taiwan.

Past two decades, his research target was to delineate the reaction mechanism of the presynaptically acting neurotoxins and, in addition to purification and characterization of presynaptic neurotoxins from snake venoms, the purification of neurotoxin acceptor/receptor from nerve tissue became the very first biochemical task.

Also, he practiced in several fields, including protein chemistry, neurochmistry, cell biology, toxicology and basic molecular biology. From those work, several neuronal proteins were found to be a potential target as either receptor for binding neurotoxin or intracellular acceptor for neurotoxic regulation. He had accomplished the biochemical characterization of neuronal receptors for several presynaptically acting neurotoxins from snake venoms by way of photoaffinity labeling and chemical cross-linking approaches, cloned and sequenced the complete/partial cDNAs for these neurotoxin-binding proteins, and expressed the proteins in E. coli system.

Chen Chih, Ph.D. Scientific Advisory Board

Chairman of SKR healthcare group and CNMT group. Former Vice President of GE & President and CEO of GE Healthcare greater China.

 

Chih Chen was born in Taiwan. He obtained his B.S degree in Civil Engineering from National Central University-Taiwan, M.S degree in Structural Engineering from University of Massachusetts and Ph.D in Mechanical Engineering from Lehigh University, Pennsylvania in 1983.

Dr. Chen then joined GE Calma Company, a Silicon Valley-based CAD/CAM company, as software engineering manager in Microelectronic R&D. In 1987, he was transferred to Taiwan as business Manager for South East Asia.

In 1989, Dr. Chen started working in GE Medical Systems as the Country Manager for Taiwan and the Philippines, then was promoted to Asia Region Service General Manager based in Singapore headquarter in 1990 and Sales/marketing General Manager in 1992. In 1994, he was appointed as General Manager of GEMMS, a newly-formed joint venture in Taiwan.

From 1996 to April 2009, Dr. Chen served as the President of GE Healthcare Greater China. He was promoted to corporate officer and Vice President of General Electric Company in 2001. In Oct. 2009, Dr. Chen established SKR healthcare group and China Nucleon Medical Technology group and serve as the chairman of both groups